Immunovant (IMVT) Other Working Capital Changes (2020 - 2021)
Immunovant's (IMVT) quarterly Other Working Capital Changes came in at -$23000.0 in Q1 2025, up 91.09% YoY from -$12036.5 in Q1 2024, and little changed on a QoQ basis from -$23000.0 in Q4 2024.
Immunovant (IMVT) Other Working Capital Changes (2020 - 2021) Analysis & Trends
Immunovant (IMVT) has 5 years of Other Working Capital Changes data on file, last reported at -$23000.0 in Q1 2025.
- Quarterly Other Working Capital Changes rose 91.09% year-over-year to -$23000.0 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was -$138000.0 (up 88.23% YoY) and the FY2026 annual result came in at -$99000.0, up 28.26% from the prior year.
- Other Working Capital Changes held at -$23000.0 in Q1 2025, from -$23000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of -$2000.0 in Q3 2020 to a low of -$544000.0 in Q4 2020.
- A 5-year average of -$227125.0 and a median of -$282500.0 in 2022 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2022 — Other Working Capital Changes tumbled 1134.78% — and 2024, when it surged 92.53%.
- Tracing IMVT's Other Working Capital Changes over 5 years: stood at -$275000.0 in 2021, then fell by 4.73% to -$288000.0 in 2022, then declined by 6.94% to -$308000.0 in 2023, then surged by 92.53% to -$23000.0 in 2024, then changed by 0.0% to -$23000.0 in 2025.
- The last three Other Working Capital Changes figures came in at -$23000.0 (Q1 2025), -$23000.0 (Q4 2024), and -$23000.0 (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Immunovant | 8.63 Bn | 7.83 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | -360,000.00 |
| Jun 30, 2021 | -360,000.00 |
| Jun 30, 2021 | -360,000.00 |
| Mar 31, 2021 | -111,000.00 |
| Mar 31, 2021 | -111,000.00 |
| Mar 31, 2021 | -111,000.00 |
| Dec 31, 2020 | -544,000.00 |
| Dec 31, 2020 | -544,000.00 |
| Dec 31, 2020 | -544,000.00 |
| Sep 30, 2020 | -2,000.00 |
| Sep 30, 2020 | -2,000.00 |
| Sep 30, 2020 | -2,000.00 |
| Jun 30, 2020 | -141,000.00 |
| Jun 30, 2020 | -141,000.00 |
| Jun 30, 2020 | -141,000.00 |